4-Aminopyrimidines as novel HIV-1 inhibitors.
Venkat R Gadhachanda, Baogen Wu, Zhiwei Wang, Kelli L Kuhen, Jeremy Caldwell, Helmut Zondler, Harald Walter, Mark Havenhand, Yun He
Index: Bioorg. Med. Chem. Lett. 17(1) , 260-5, (2007)
Full Text: HTML
Abstract
A series of 4-aminopyrimidines (1) was identified as novel HIV inhibitors of unknown molecular target. Structural modifications were carried out to establish its SAR and identify the linking site for target identification. A number of analogs were found to possess single digit inhibitory activity for HIV replication. Several analogs with various potential linkers, including a biotinated analog, also exhibited excellent potency, and could serve as tools for the identification of novel anti-HIV targets.
Related Compounds
Related Articles:
2014-07-15
[Pain 156 , 1620-36, (2015)]
Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus.
2015-03-18
[J. Neurosci. 35(11) , 4540-51, (2015)]
2014-08-01
[J. Pharmacol. Exp. Ther. 350(2) , 301-12, (2014)]
Formation of 4-aminopyrimidines via the trimerization of nitriles using focused microwave heating.
2005-01-01
[J. Comb. Chem. 7(3) , 483-9, (2005)]
2012-02-29
[J. Am. Chem. Soc. 134(8) , 3873-85, (2012)]